Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Neurobiol Dis ; 191: 106408, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38199274

ABSTRACT

Excitotoxicity arises from unusually excessive activation of excitatory amino acid receptors such as glutamate receptors. Following an energy crisis, excitotoxicity is a major cause for neuronal death in neurological disorders. Many glutamate antagonists have been examined for their efficacy in mitigating excitotoxicity, but failed to generate beneficial outcome due to their side effects on healthy neurons where glutamate receptors are also blocked. In this study, we found that during chronic hypoxia there is upregulation and activation of a nonselective cation channel TRPM4 that contributes to the depolarized neuronal membrane potential and enhanced glutamate-induced calcium entry. TRPM4 is involved in modulating neuronal membrane excitability and calcium signaling, with a complex and multifaceted role in the brain. Here, we inhibited TRPM4 using a newly developed blocking antibody M4P, which could repolarize the resting membrane potential and ameliorate calcium influx upon glutamate stimulation. Importantly, M4P did not affect the functions of healthy neurons as the activity of TRPM4 channel is not upregulated under normoxia. Using a rat model of chronic hypoxia with both common carotid arteries occluded, we found that M4P treatment could reduce apoptosis in the neurons within the hippocampus, attenuate long-term potentiation impairment and improve the functions of learning and memory in this rat model. With specificity to hypoxic neurons, TRPM4 blocking antibody can be a novel way of controlling excitotoxicity with minimal side effects that are common among direct blockers of glutamate receptors.


Subject(s)
Glutamic Acid , TRPM Cation Channels , Rats , Animals , Glutamic Acid/metabolism , Calcium/metabolism , Receptors, Glutamate/metabolism , Neurons/metabolism , Hypoxia/metabolism , TRPM Cation Channels/metabolism
2.
J Neurosci ; 32(3): 1020-34, 2012 Jan 18.
Article in English | MEDLINE | ID: mdl-22262900

ABSTRACT

The deregulation of cyclin-dependent kinase 5 (Cdk5) by p25 has been shown to contribute to the pathogenesis in a number of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD) and Alzheimer's disease (AD). In particular, p25/Cdk5 has been shown to produce hyperphosphorylated tau, neurofibrillary tangles as well as aberrant amyloid precursor protein processing found in AD. Neuroinflammation has been observed alongside the pathogenic process in these neurodegenerative diseases, however the precise mechanism behind the induction of neuroinflammation and the significance in the AD pathogenesis has not been fully elucidated. In this report, we uncover a novel pathway for p25-induced neuroinflammation where p25 expression induces an early trigger of neuroinflammation in vivo in mice. Lipidomic mass spectrometry, in vitro coculture and conditioned media transfer experiments show that the soluble lipid mediator lysophosphatidylcholine (LPC) is released by p25 overexpressing neurons to initiate astrogliosis, neuroinflammation and subsequent neurodegeneration. Reverse transcriptase PCR and gene silencing experiments show that cytosolic phospholipase 2 (cPLA2) is the key enzyme mediating the p25-induced LPC production and cPLA2 upregulation is critical in triggering the p25-mediated inflammatory and neurodegenerative process. Together, our findings delineate a potential therapeutic target for the reduction of neuroinflammation in neurodegenerative diseases including AD.


Subject(s)
Inflammation/metabolism , Lysophosphatidylcholines/metabolism , Nerve Degeneration/metabolism , Nerve Tissue Proteins/metabolism , Neurons/enzymology , Phospholipases A2, Cytosolic/pharmacology , Age Factors , Amyloid beta-Peptides/metabolism , Animals , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Cells, Cultured , Cerebral Cortex/cytology , Chromatography, High Pressure Liquid/methods , Coculture Techniques , Culture Media, Conditioned/pharmacology , Cytokines/metabolism , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/genetics , Glial Fibrillary Acidic Protein/metabolism , Gliosis/etiology , Gliosis/genetics , Green Fluorescent Proteins/genetics , Humans , In Situ Nick-End Labeling/methods , Inflammation/genetics , Mass Spectrometry/methods , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Degeneration/genetics , Nerve Tissue Proteins/genetics , Neuroglia/physiology , Neurons/drug effects , Peptide Fragments/metabolism , Phospholipases A2, Cytosolic/genetics , Phosphotransferases , RNA, Small Interfering/metabolism , Signal Transduction/genetics , Time Factors , Transduction, Genetic , tau Proteins/metabolism
3.
J Neurosci ; 30(25): 8457-67, 2010 Jun 23.
Article in English | MEDLINE | ID: mdl-20573893

ABSTRACT

Cyclin-dependent kinase 5 (Cdk5)-mediated phosphorylation plays an important role in proper synaptic function and transmission. Loss of Cdk5 activity results in abnormal development of the nervous system accompanied by massive disruptions in cortical migration and lamination, therefore impacting synaptic activity. The Cdk5 activator p35 associates with delta-catenin, the synaptic adherens junction protein that serves as part of the anchorage complex of AMPA receptor at the postsynaptic membrane. However, the implications of Cdk5-mediated phosphorylation of delta-catenin have not been fully elucidated. Here we show that Cdk5-mediated phosphorylation of delta-catenin regulates its subcellular localization accompanied by changes in dendritic morphogenesis and synaptic activity. We identified two Cdk5 phosphorylation sites in mouse delta-catenin, serines 300 and 357, and report that loss of Cdk5 phosphorylation of delta-catenin increased its localization to the membrane. Furthermore, mutations of the serines 300 and 357 to alanines to mimic nonphosphorylated delta-catenin resulted in increased dendritic protrusions accompanied by increased AMPA receptor subunit GluR2 localization at the membrane. Consistent with these observations, loss of Cdk5 phosphorylation of delta-catenin increased the AMPA/NMDA ratio. This study reveals how Cdk5 phosphorylation of the synaptic mediator protein delta-catenin can alter its localization at the synapse to impact neuronal synaptic activity.


Subject(s)
Catenins/metabolism , Cyclin-Dependent Kinase 5/metabolism , Neurons/metabolism , Receptors, AMPA/metabolism , Synapses/metabolism , Synaptic Transmission/physiology , Animals , Cells, Cultured , Cerebral Cortex/metabolism , Electrophysiology , Immunohistochemistry , Mice , Mutation , Nerve Tissue Proteins/metabolism , Neurons/cytology , Phosphorylation , Radioligand Assay , Delta Catenin
SELECTION OF CITATIONS
SEARCH DETAIL